Ashford Capital Management’s HealthEquity HQY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $22.3M | Sell |
266,481
-5,242
| -2% | -$430K | 2.75% | 10 |
|
|
2025
Q4 | $24.9M | Sell |
271,723
-240
| -0.1% | -$23K | 2.77% | 10 |
|
|
2025
Q3 | $25.8M | Sell |
271,963
-7,441
| -3% | -$700K | 2.87% | 11 |
|
|
2025
Q2 | $29.3M | Buy |
279,404
+4,405
| +2% | +$418K | 3.44% | 6 |
|
|
2025
Q1 | $24.3M | Buy |
274,999
+5,687
| +2% | +$583K | 3.13% | 7 |
|
|
2024
Q4 | $25.8M | Sell |
269,312
-35,910
| -12% | -$3.35M | 3.05% | 10 |
|
|
2024
Q3 | $25M | Sell |
305,222
-2,460
| -0.8% | -$190K | 3.12% | 9 |
|
|
2024
Q2 | $26.5M | Sell |
307,682
-33,830
| -10% | -$2.73M | 3.58% | 6 |
|
|
2024
Q1 | $27.9M | Sell |
341,512
-67,170
| -16% | -$5.24M | 3.77% | 6 |
|
|
2023
Q4 | $27.1M | Buy |
408,682
+4,403
| +1% | +$305K | 3.63% | 5 |
|
|
2023
Q3 | $29.5M | Sell |
404,279
-15,510
| -4% | -$1.05M | 4.35% | 2 |
|
|
2023
Q2 | $26.5M | Buy |
419,789
+20,983
| +5% | +$1.22M | 3.7% | 7 |
|
|
2023
Q1 | $23.4M | Buy |
398,806
+69,702
| +21% | +$4.23M | 3.51% | 9 |
|
|
2022
Q4 | $20.3M | Sell |
329,104
-10,727
| -3% | -$721K | 3.15% | 12 |
|
|
2022
Q3 | $22.8M | Sell |
339,831
-18,217
| -5% | -$1.15M | 3.48% | 5 |
|
|
2022
Q2 | $22M | Buy |
358,048
+3,758
| +1% | +$241K | 3.12% | 9 |
|
|
2022
Q1 | $23.9M | Buy |
354,290
+31,220
| +10% | +$1.69M | 2.57% | 13 |
|
|
2021
Q4 | $14.3M | Sell |
323,070
-40,611
| -11% | -$2.37M | 1.43% | 32 |
|
|
2021
Q3 | $23.6M | Buy |
363,681
+48,996
| +16% | +$3.4M | 2.14% | 18 |
|
|
2021
Q2 | $25.3M | Sell |
314,685
-645
| -0.2% | -$49.1K | 2.28% | 17 |
|
|
2021
Q1 | $21.4M | Sell |
315,330
-4,443
| -1% | -$349K | 2% | 22 |
|
|
2020
Q4 | $22.3M | Sell |
319,773
-53,700
| -14% | -$3.34M | 2.16% | 20 |
|
|
2020
Q3 | $19.2M | Sell |
373,473
-26,842
| -7% | -$1.47M | 2.28% | 16 |
|
|
2020
Q2 | $23.5M | Sell |
400,315
-52,389
| -12% | -$2.9M | 3.04% | 12 |
|
|
2020
Q1 | $22.9M | Buy |
452,704
+138,579
| +44% | +$9.2M | 4.04% | 4 |
|
|
2019
Q4 | $23.3M | Buy |
314,125
+2,100
| +0.7% | +$131K | 3.11% | 10 |
|
|
2019
Q3 | $17.8M | Buy |
312,025
+79,097
| +34% | +$5.25M | 2.58% | 16 |
|
|
2019
Q2 | $15.2M | Sell |
232,928
-3,000
| -1% | -$209K | 2.04% | 24 |
|
|
2019
Q1 | $17.5M | Buy |
235,928
+89,839
| +61% | +$6.32M | 2.55% | 19 |
|
|
2018
Q4 | $8.71M | Buy |
146,089
+3,300
| +2% | +$266K | 1.43% | 29 |
|
|
2018
Q3 | $13.5M | Buy |
142,789
+2,800
| +2% | +$241K | 1.63% | 26 |
|
|
2018
Q2 | $10.5M | Buy |
+139,989
| New | +$10.1M | 1.39% | 27 |
|
Other funds holding HQY
WA
VPM
VCM
Ashford Capital Management's HQY Position: Q1 2026 in Review
Ashford Capital Management reduced its HealthEquity (HQY) stake by 1.9% in Q1 2026, selling an estimated $430K and leaving 266,481 shares worth $22.3M. The position accounts for 2.75% of the portfolio, ranked #10.
Ashford Capital Management first reported a position in HQY in Q2 2018 and has held it in 32 quarters since. The position peaked at $29.5M in Q3 2023. 485 funds tracked by Wall St. Rank hold HQY as of Q1 2026.
- Ashford Capital Management held 266,481 shares of HealthEquity worth $22.3M as of Q1 2026.
- Ashford Capital Management sold 5,242 HealthEquity shares in Q1 2026, an estimated $430K.
- HealthEquity made up 2.75% of Ashford Capital Management's portfolio in Q1 2026, its #10 holding.
- Ashford Capital Management first reported a position in HealthEquity in Q2 2018 and has held it in 32 quarters since.
- Ashford Capital Management's HealthEquity position peaked at $29.5M in Q3 2023.
- 485 funds tracked by Wall St. Rank held HealthEquity as of Q1 2026.
Based on Ashford Capital Management's 13F filing for Q1 2026, filed 15 May 2026.